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4 hormone-based therapies including GnRH agonists and antagonists. [1, 2, 5 , 10] Recent studies have taken advantage of this differential receptor expression and used a modified GnRH peptide as a targeting moiety to enhance the relative uptake by cancer cells and decrease the relative availability to normal cells. [1, 2, 4, 8, 11] Targeting anticancer drugs to tumours may assist in improving the drugs specificity, reducing toxicity to normal cells, and reducing the possibility of multidrug resistance. [3] [4] [5] GnRH analogues are recognised by a broad variety of GnRH-receptor positive, but not receptor negative, cells. [4, 6, 12] Using small peptides instead of conventional protein macromolecules has many advantages including ease of preparation, lower antigenicity, and increased stability. GnRH analogue-modified carriers have been used for selective delivery of diagnostic and therapeutic agents to cancer cells that overexpress the GnRH receptor. [4, 13] This ligand-targeted delivery results in increased internalisation and more effective delivery of anticancer drugs, thus overcoming the problem of multidrug resistance and toxic effects of cytotoxic drugs on normal cells. [8, 13] Extension of the GnRH C-and N-terminals by addition of lipids improves the half-life of the peptide when used in oral drug delivery applications. [14] Natural lipidation of proteins causes a change in hydrophobicity and conformation, which promotes localisation to specific subcellular compartments. [15] In this study, lipids were included in the constructs to aid peptide self-assembly and to increase drug targeting potential. [13, 16, 17] It is known that hydrophobic modifications such as the posttranslational lipidation of proteins can result in higher membrane binding affinity, thereby affecting protein localisation and functioning. In the present study, lipids were assembled on a poly-lysine core which was included to enhance self-assembly properties. The peptide analogue [Gln 1 ]-GnRH (GnRH-1) was included as a targeting agent ( Figure 1 ).
A C C E P T E D M A N U S C R I P T
To investigate whether lipidated GnRH-1 analogues could be specifically targeted in vitro towards GnRH-receptor positive cells, their uptake into PC-3 prostate cancer cells was compared to that of GnRH-receptor negative SKOV-3 ovarian cancer cells. Furthermore, the direct effect of these GnRH-1 analogues was examined in vitro on the proliferation of three classic GnRH-receptor positive tumour cell lines; PC-3, LNCaP, DU145, and normal peripheral blood mononuclear cells (PBMCs) isolated from whole blood.
Methods

General
Dimethylformamide (DMF), trifluoroacetic acid (TFA), and piperidine of peptide synthesis grade were purchased from Merck Biosciences (Kilsyth, VIC, Australia). 5(6)-carboxyfluorescein (5-FAM) was purchased from Sigma Aldrich (St Louis, MO, USA). Table 1 .
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Particle Size and Zeta Potential Measurement
Lyophilised peptides were dispersed by vortexing in deionised water at a concentration of 1 mg/ml and leaving for 60 min prior to analysis. Measurements were performed in triplicate.
Tissue Culture
All cells were maintained in T-75 flasks at 37 °C in a humidified atmosphere of 5% CO 2 and 95% air. PC-3 and SKOV-3 were cultured in DMEM, LNCaP and DU145 in RPMI-1640 that was supplemented with 10% FBS, penicillin/streptomycin and 1% non-essential amino acids.
Uptake by Flow Cytometry
SKOV-3 and PC-3 cells were seeded into 24-well plastic plates at a density of 1.0 x 10 5 cells per well and allowed to adhere overnight. Culture medium was removed and replaced with fresh DMEM that contained fluorescently-labelled GnRH-1 peptides at 10 µM and the cells were incubated for a further 4 h at 37 °C. Cells were washed with 1 ml PBS (3x)
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9 and trypsinised using TrypLE Express (0.1 ml) for 5 min at 37 °C before being resuspended in 0.6 ml PBS and placed into tubes for flow cytometry. To detect the intracellular concentration of peptide, cells were treated with trypan blue (TB, 0.4%) 30 seconds prior to flow analysis to quench the surface-bound fluorescence.
[23] Cells grown in the absence of GnRH-1 analogues were used as controls.
Fluorescence Microscopy
Cells were seeded and treated as per flow cytometry experiments. After 4 h incubation with the labelled peptide, cells were washed with 1 ml PBS (3x), treated with TB (0.4%) to quench surface bound peptide, and washed with 1 ml PBS. Cells were visualised using an Olympus IX51 inverted fluorescence microscope. Fluor 647 for 45 min at RT and mounted using Vectorshield mounting medium with DAPI.
Triptorelin Competition Assay
SKOV
Slides were visualised using an Olympus BX61 confocal microscope.
Calculations
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Binding index was calculated as a ratio of geometric mean fluorescence of PC-3 and SKOV-3 cells (fluorescence relative to negative control) in order to normalise fluorescence in both cell lines. Data are presented as mean ± SD. Differences between groups was determined using two-way analysis of variance (ANOVA) followed by the Tukey post hoc test and were considered statistically significant if P value was <0.05.
Isolation of peripheral blood mononuclear cells (PBMCs)
Assay was performed with the approval from the University of Queensland Ethics 
Results
Peptide Synthesis and Characterisation
The amino acid sequences of the GnRH-1 derivatives and triptorelin ([w   6 ]-GnRH, a clinically available superagonist) are shown in Figure 1 and Table 1 , respectively. Pure lipidic peptides were readily synthesised using step-wise Fmoc SPPS (see Supplementary
Information for a detailed synthetic scheme). The lipidic moiety consisting of two synthetic lipoamino acids was synthesised as a diastereomeric mixture at the C-or N-terminus of the constructs ( Figure 1) . A fluorescent tag (5-FAM, Figure 1 ) was coupled to the N-terminus of the GnRH-1 analogues using HOBT and DIC. This step was performed in the dark to limit photo-bleaching. Removal of additional fluorophore esters was achieved by subsequent treatment of the resin with piperidine or until no further colour was observed when washed.
This diastereomeric mixture resulted in broad or twin peaks in HPLC for each lipidated peptide analogue with a single peak observed for non-lipidated peptides (see Supplementary information). Following TFA cleavage, all crude compounds were purified by PR-HPLC using C18 or C4 column to >98% purity. The lyophilised peptides were obtained in 22-63% yields, characterised by ESI-MS and their purity confirmed by analytical HPLC ( Table 1) .
Incorporation of the lipids results in a diastereomeric mixture that was not separated prior to in vitro analysis. Peptide dendrimers were assessed for their relative nanoparticular size in water to identify any significant changes between the N-and C-terminal lipidated constructs.
In this study all peptides were greater than 100 nm in diameter (Table 2) .
A C C E P T E D M A N U S C R I P T
In Vitro Evaluation
Cell Uptake study
In vitro GnRH receptor-mediated uptake and internalisation of the GnRH-1 analogues was evaluated using GnRH-receptor over expressing PC-3 cells and low expressing SKOV-3 cells by flow cytometry and microscopy. TB was used as an extracellular quencher to distinguish between cell-associated fluorescence and fluorescence due to internalisation of peptide analogues. Optimisation of TB quenching (data not shown) was performed and found that addition of 0.4% TB 30 seconds before flow analysis gave higher quenching than addition of TB prior to the cell trypsination step.
Peptide concentration and incubation times were optimised in preliminary studies (data not shown). Figure 4D ). Analogue 6 also showed significant uptake (Figure 2 and 3) , but as the uptake was lower than 4, it was not investigated further.
Cellular uptake of analogue 4 using confocal microscopy ( Figure 5 ) in the absence and presence of competitor triptorelin was performed. Here, the nucleus is stained with DAPI, the GnRH-1 analogue is labelled with a fluorescent tag (5-FAM), and the cell membrane stained with Alexa Fluor 647. In the absence of triptorelin, granule formation is observed in the cytosol of PC-3 cells but negligible uptake is observed when triptorelin is present. In receptor negative SKOS-3 cells, no internalisation is observed in the absence or presence of triptorelin; however, non-specific binding localised to the outer cell membrane is observed in both cell lines and is not inhibited by triptorelin treatment. Localisation of the GnRH-1 analogue appears to be isolated to the cytosol with negligible present in the nucleus.
Tumour cell growth study
GnRH-1 dendrimers and triptorelin were studied for their direct antiproliferative Table   3 ). This effect of the compound was higher than that of triptorelin with an IC 50 value of 78 µM. Compound 5 produced significant reduction in the viability of DU145 cells (35%) only at 50 µM (p<0.05).
Evaluation of GnRH-1 analogues toxicity on PBMCs
Cell toxicity of dendrimers 1-6 was evaluated in normal PBMCs isolated from whole blood. All compounds were found to be non-toxic to PBMCs at the two concentrations used for cancer cell proliferation studies (Figure 6d) . A slight increase in the proliferation (20-30%) was observed in the cells treated with compounds 2, 5 and 6 at the lower concentration, 25 µM.
Discussion
GnRH-1 analogues used in this study contained either two GnRH-1 epitopes organised in a dendritic manner (Figure 1 
Conclusion
The present study provides evidence that dendritic GnRH-1 analogues facilitated specific uptake by prostate cancer cells that overexpress the GnRH receptor. Additionally, our results showed that non-specific binding was increased when a lipid was present in the Nuclei were stained with DAPI (blue). Analysis was performed on an Olympus BX61 upright confocal microscope at 60x using oil immersion. 
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